Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03777267 · ClinicalTrials.gov registry record · NA

Cereset Research Exploratory Study

A NA study of Neurological Diseases or Conditions and Cardiovascular Conditions After Birth, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT03777267 is a NA study of Neurological Diseases or Conditions and Cardiovascular Conditions After Birth that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03777267, a NA study of Neurological Diseases or Conditions and Cardiovascular Conditions After Birth, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.

Interventions

  • DEVICE Active CR

Study Locations (1)

North Carolina

  • Wake Forest University Health Scienc\ess - Winston-Salem

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2019-04-12
Est. Completion 2027-04
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT03777267

The ClinicalTrials.gov registry entry for NCT03777267 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Neurological Diseases or Conditions appearing as the primary indexed condition, and to 1 intervention - of which Active CR is the first listed.

NCT03777267 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT03777267 about?

NCT03777267 is a clinical study titled "Cereset Research Exploratory Study". The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.

What is the current status of trial NCT03777267?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2019-04-12. Estimated completion is 2027-04.

What conditions does trial NCT03777267 study?

This clinical trial studies the following conditions: Neurological Diseases or Conditions, Cardiovascular Conditions After Birth, Psychophysiologic Disorders.

What interventions are being tested in trial NCT03777267?

The interventions under investigation include: Active CR (DEVICE).

Who is sponsoring clinical trial NCT03777267?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03777267 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.